The 340B Drug Pricing Program

Oversight and Investigations Subcommittee Hearing: “Oversight of 340B Drug Pricing Program”

340B Drug Pricing Program Compliance | JD Supra

Yesterday’s Senate HELP Committee hearing confirmed what a growing body of evidence has shown: the 340B program is being exploited by large hospitals and it is driving up costs for patients, taxpayers and employers. Big hospitals are buying medicines at steep discounts and marking them up by 1,000% or more. If patients aren’t benefiting, where is the money going? Testimony from Dr. Aditi Sen of the nonpartisan Congressional Budget Office underscored that the 340B program incentivizes practices t

The federal 340B program requires drug makers to sell their products to some hospitals at a discount. Hospitals and contract pharmacies can then resell them and pocket the difference. It’s a case of the government picking winners (hospitals) and losers (drug manufacturers) among private market participants. Hospitals argue that they need the money to help patients. That is, they use the extra revenue from the program to cut costs or provide free care for those in need. But Jarrett Skorup of the

Ben’s story is just one example of how the #340B drug pricing program has helped Michigan patients access critical, community-based care close to home. To learn more or contact your lawmakers to urge they #Protect340B, visit: https://bit.ly/3MTH8l8 | Michigan Health & Hospital Association | Facebook

583 views | Reel by Citizens Against Government Waste